Increased risk of fatal prostate cancer may explain the rise in mortality in the Netherlands

International Journal of Epidemiology

Volumn 28, Issue 3, 1999, Pages 403-408

  Post, Piet N ^a,b   Straatman, Huub ^c   Kiemeney, Lambertus A L M ^c   Coebergh, Jan Willem W ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b The Netherlands   (Netherlands)

^c NONE

Author keywords

Birth cohorts; Mortality; Prostate cancer; Statistical modelling; Trends

Indexed keywords

CANCER; DISEASE PREVALENCE; MORTALITY; RISK FACTOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

NETHERLANDS;

EID: 0033001080     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.3.403     Document Type: Article

References (25)

1. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121. Lyon: IARC, 1993, pp.499-520.
2. Post PN, Kil PJM, Crommelin MA, Schapers RFM, Coebergh JWW. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971-1995. Eur J Cancer 1998;34:705-09.
3. Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM (eds). Incidence of Cancer in The Netherlands 1994. Utrecht: Vereniging van Integrale Kankercentra, 1997.
4. Van der Gulden JWJ, Kiemeney LALM, Verbeek ALM, Straatman H. Mortality trend from prostate cancer in the Netherlands (1950-1989). Prostate 1994;24:33-38.
5. Kosary CL, Ries LAG, Miller BA, Hankey BF, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, MD: National Cancer Institute. NIH publ. No. 96-2789, 1995, 395.
6. Helgesen F, Holmberg L, Johansson JE, Bergström R, Adami HO. Trend in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumours. J Natl Cancer Inst 1996;88:1216-21.
7. Post PN, Stockton D, Davies TW, Coebergh JWW. Striking increase of prostate cancer in men aged <60 years without improvement in prognosis. Br J Cancer 1999;79:13-17.
8. Central Bureau of Statistics. Mortality by Cause of Death, 1955-1977 (in Dutch). The Hague: SDU Publishers, 1980.
9. Central Bureau of Statistics. Mortality by Cause of Death, Age and Sex in the Years (1978-) 1994 Series Al (in Dutch). The Hague: SDU Publishers, 1996.
10. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age period and age cohort models. Stat Med 1987;6:449-67.
11. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987;6:469-81.
12. Breslow NE. Extra-Poisson variation in log-linear models. Appl Stat 1984;33:38-44.
13. Harvei S, Tretli S, Langmark F. Cancer of the prostate in Norway 1957-1991 - A descriptive study. Eur J Cancer 1996;32A:111-17.
14. Grönberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Ångström T. Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta Oncol 1994;33:359-63.
15. Ménégoz F, Colonna M, Exbrayat C, Mousseau M, Orfeuvre H, Schaerer R. A recent increase in the incidence of prostatic carcinoma in a French population: role of ultrasonography and prostate-specific antigen. Eur J Cancer 1995;31A:55-58.
16. Cayuela A, Lacalle JR, Gili M. Analysis of cohort mortality from prostatic cancer in Spain, 1951-1983. J Epidemiol Community Health 1989;43:249-52.
17. Boyle P, Maisonneuve P, Napalkov P. Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 1995;46:47-55.
18. La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998;34:118-41.
19. Central Bureau of Statistics. Mortality by Some Main Causes of Death, 1970-1990. The Hague: SDU Publishers, 1992.
20. Janssen-Heijnen MLG, Nab HW, van Reek J, van der Heijden LH, Schipper R, Coebergh JWW. Striking changes in smoking behaviour and lung cancer incidence by histological type in Southeast Netherlands, 1960-1991. Eur J Cancer 1995;31A:949-52.
21. La Vecchia C, Levi F, Lucchini F. Mortality from benign prostatic hyperplasia: worldwide trends in 1950-92. J Epidemiol Community Health 1995;49:379-84.
22. Breslow N, Chan CE, Dhom G. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977;20:680-88.
23. Carter B, Bova G, Beaty T et al. Hereditary prostate cancer: epidemiological and clinical features. J Urol 1993;150:797-802.
24. Mettlin C. Recent developments in the epidemiology of prostate cancer. Eur J Cancer 1997;33:340-47.
25. Ekbom A, Hsieh C-C, Lipworth L et al. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. Br Med J 1996;313:337-41.